Cargando…

Malignancy-Associated Dyslipidemia

Cholesterol and triglycerides, important lipid constituents of cell, are essential to carry out several vital physiological functions. Lipids might be associated with cancers because they play a key role in the maintenance of cell integrity. The pathway for cholesterol synthesis may also produce var...

Descripción completa

Detalles Bibliográficos
Autores principales: Bielecka-Dąbrowa, Agata, Hannam, Simon, Rysz, Jacek, Banach, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109950/
https://www.ncbi.nlm.nih.gov/pubmed/21660223
http://dx.doi.org/10.2174/1874192401105010035
_version_ 1782205477941149696
author Bielecka-Dąbrowa, Agata
Hannam, Simon
Rysz, Jacek
Banach, Maciej
author_facet Bielecka-Dąbrowa, Agata
Hannam, Simon
Rysz, Jacek
Banach, Maciej
author_sort Bielecka-Dąbrowa, Agata
collection PubMed
description Cholesterol and triglycerides, important lipid constituents of cell, are essential to carry out several vital physiological functions. Lipids might be associated with cancers because they play a key role in the maintenance of cell integrity. The pathway for cholesterol synthesis may also produce various tumorigenic compounds and cholesterol serves as a precursor for the synthesis of many sex hormones linked to increased risk of various cancers. In some malignant diseases, blood cholesterol undergoes early and significant changes. The mechanism for the link between cancer and cholesterol remains controversial. The dates from studies are confusing because both hypolipidemia and hypercholesterolemia might be connected with malignancy. Not only cancers but also antineoplastic therapies have an influence on lipid profile. There are also dates suggesting that antihyperlipemic drugs might nfluenced malignancy.
format Online
Article
Text
id pubmed-3109950
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-31099502011-06-09 Malignancy-Associated Dyslipidemia Bielecka-Dąbrowa, Agata Hannam, Simon Rysz, Jacek Banach, Maciej Open Cardiovasc Med J Article Cholesterol and triglycerides, important lipid constituents of cell, are essential to carry out several vital physiological functions. Lipids might be associated with cancers because they play a key role in the maintenance of cell integrity. The pathway for cholesterol synthesis may also produce various tumorigenic compounds and cholesterol serves as a precursor for the synthesis of many sex hormones linked to increased risk of various cancers. In some malignant diseases, blood cholesterol undergoes early and significant changes. The mechanism for the link between cancer and cholesterol remains controversial. The dates from studies are confusing because both hypolipidemia and hypercholesterolemia might be connected with malignancy. Not only cancers but also antineoplastic therapies have an influence on lipid profile. There are also dates suggesting that antihyperlipemic drugs might nfluenced malignancy. Bentham Open 2011-02-24 /pmc/articles/PMC3109950/ /pubmed/21660223 http://dx.doi.org/10.2174/1874192401105010035 Text en © Bielecka-Dąbrowa et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Bielecka-Dąbrowa, Agata
Hannam, Simon
Rysz, Jacek
Banach, Maciej
Malignancy-Associated Dyslipidemia
title Malignancy-Associated Dyslipidemia
title_full Malignancy-Associated Dyslipidemia
title_fullStr Malignancy-Associated Dyslipidemia
title_full_unstemmed Malignancy-Associated Dyslipidemia
title_short Malignancy-Associated Dyslipidemia
title_sort malignancy-associated dyslipidemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109950/
https://www.ncbi.nlm.nih.gov/pubmed/21660223
http://dx.doi.org/10.2174/1874192401105010035
work_keys_str_mv AT bieleckadabrowaagata malignancyassociateddyslipidemia
AT hannamsimon malignancyassociateddyslipidemia
AT ryszjacek malignancyassociateddyslipidemia
AT banachmaciej malignancyassociateddyslipidemia